| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dementia | 10 | 2024 | 516 | 2.350 |
Why?
|
| Cognitive Dysfunction | 21 | 2024 | 998 | 2.210 |
Why?
|
| Alzheimer Disease | 23 | 2024 | 1981 | 2.050 |
Why?
|
| Brain | 17 | 2023 | 1626 | 1.340 |
Why?
|
| Models, Statistical | 3 | 2016 | 115 | 1.190 |
Why?
|
| Cognition Disorders | 11 | 2023 | 939 | 1.160 |
Why?
|
| Aged | 58 | 2024 | 8400 | 1.100 |
Why?
|
| Aging | 18 | 2023 | 1520 | 1.070 |
Why?
|
| Longitudinal Studies | 19 | 2023 | 1300 | 1.050 |
Why?
|
| Humans | 87 | 2024 | 25181 | 0.980 |
Why?
|
| Aged, 80 and over | 42 | 2024 | 4503 | 0.970 |
Why?
|
| Cognition | 15 | 2023 | 1263 | 0.890 |
Why?
|
| Software | 1 | 2023 | 65 | 0.880 |
Why?
|
| Radar | 1 | 2022 | 6 | 0.800 |
Why?
|
| Female | 65 | 2023 | 13845 | 0.790 |
Why?
|
| Male | 64 | 2023 | 13545 | 0.790 |
Why?
|
| Algorithms | 3 | 2023 | 351 | 0.790 |
Why?
|
| Music | 1 | 2021 | 18 | 0.720 |
Why?
|
| Literacy | 1 | 2021 | 16 | 0.720 |
Why?
|
| Death | 1 | 2021 | 45 | 0.720 |
Why?
|
| Educational Status | 2 | 2021 | 279 | 0.710 |
Why?
|
| Risk Factors | 23 | 2023 | 2167 | 0.690 |
Why?
|
| Depression | 6 | 2020 | 395 | 0.670 |
Why?
|
| Diabetes Mellitus | 6 | 2023 | 122 | 0.650 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.640 |
Why?
|
| Influenza, Human | 9 | 2015 | 39 | 0.640 |
Why?
|
| Orthomyxoviridae Infections | 7 | 2015 | 9 | 0.610 |
Why?
|
| Depressive Disorder | 1 | 2019 | 163 | 0.600 |
Why?
|
| Data Interpretation, Statistical | 2 | 2016 | 84 | 0.540 |
Why?
|
| Biostatistics | 1 | 2016 | 5 | 0.540 |
Why?
|
| Brazil | 5 | 2021 | 35 | 0.510 |
Why?
|
| Cohort Studies | 15 | 2022 | 1757 | 0.490 |
Why?
|
| Zoonoses | 8 | 2015 | 9 | 0.490 |
Why?
|
| Odds Ratio | 3 | 2018 | 243 | 0.450 |
Why?
|
| Blood Pressure | 3 | 2020 | 200 | 0.450 |
Why?
|
| Intracranial Aneurysm | 4 | 2018 | 27 | 0.450 |
Why?
|
| Influenza A virus | 5 | 2012 | 15 | 0.440 |
Why?
|
| Neuropsychological Tests | 12 | 2023 | 1189 | 0.440 |
Why?
|
| Body Mass Index | 4 | 2023 | 393 | 0.440 |
Why?
|
| Cerebrovascular Disorders | 3 | 2021 | 130 | 0.420 |
Why?
|
| Brain Infarction | 3 | 2020 | 73 | 0.400 |
Why?
|
| Seroepidemiologic Studies | 7 | 2010 | 18 | 0.400 |
Why?
|
| Swine Diseases | 5 | 2012 | 5 | 0.400 |
Why?
|
| Hospitalization | 3 | 2019 | 282 | 0.390 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2023 | 114 | 0.390 |
Why?
|
| Antibodies, Viral | 9 | 2015 | 50 | 0.390 |
Why?
|
| Memory, Episodic | 3 | 2023 | 114 | 0.390 |
Why?
|
| Occupational Exposure | 8 | 2015 | 17 | 0.390 |
Why?
|
| Insulin | 3 | 2021 | 74 | 0.380 |
Why?
|
| Neuropathology | 3 | 2022 | 82 | 0.360 |
Why?
|
| Family | 2 | 2021 | 88 | 0.340 |
Why?
|
| Amyloid beta-Peptides | 4 | 2023 | 306 | 0.340 |
Why?
|
| DNA-Binding Proteins | 5 | 2019 | 250 | 0.330 |
Why?
|
| Stress, Psychological | 3 | 2021 | 206 | 0.320 |
Why?
|
| Prospective Studies | 9 | 2023 | 1588 | 0.320 |
Why?
|
| Autopsy | 8 | 2023 | 336 | 0.310 |
Why?
|
| Hippocampus | 4 | 2022 | 247 | 0.300 |
Why?
|
| Disease Progression | 4 | 2021 | 649 | 0.300 |
Why?
|
| Child, Preschool | 8 | 2022 | 588 | 0.300 |
Why?
|
| Swine | 8 | 2012 | 60 | 0.300 |
Why?
|
| Animals | 16 | 2022 | 3378 | 0.290 |
Why?
|
| Communicable Diseases | 1 | 2007 | 20 | 0.280 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2019 | 25 | 0.280 |
Why?
|
| Disease Outbreaks | 3 | 2013 | 76 | 0.280 |
Why?
|
| Cognitive Aging | 2 | 2018 | 73 | 0.270 |
Why?
|
| HIV Infections | 2 | 2021 | 432 | 0.260 |
Why?
|
| Adenoviruses, Human | 3 | 2009 | 4 | 0.250 |
Why?
|
| Neurodegenerative Diseases | 2 | 2018 | 109 | 0.250 |
Why?
|
| Middle Aged | 23 | 2021 | 8136 | 0.250 |
Why?
|
| Adenovirus Infections, Human | 3 | 2009 | 3 | 0.240 |
Why?
|
| Perception | 3 | 2021 | 73 | 0.240 |
Why?
|
| Intracranial Arteriosclerosis | 3 | 2021 | 53 | 0.240 |
Why?
|
| Arteriolosclerosis | 2 | 2023 | 78 | 0.240 |
Why?
|
| Cytomegalovirus Infections | 2 | 2015 | 35 | 0.230 |
Why?
|
| Nervous System Diseases | 2 | 2023 | 117 | 0.230 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2008 | 14 | 0.220 |
Why?
|
| Interviews as Topic | 2 | 2021 | 113 | 0.220 |
Why?
|
| Signal Transduction | 3 | 2021 | 380 | 0.220 |
Why?
|
| Independent Living | 3 | 2021 | 305 | 0.220 |
Why?
|
| Metformin | 1 | 2023 | 18 | 0.220 |
Why?
|
| Computer Simulation | 2 | 2016 | 191 | 0.220 |
Why?
|
| United States | 11 | 2024 | 1899 | 0.210 |
Why?
|
| Acculturation | 1 | 2023 | 36 | 0.210 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 12 | 0.210 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2023 | 28 | 0.210 |
Why?
|
| Risk Assessment | 3 | 2022 | 592 | 0.210 |
Why?
|
| Atherosclerosis | 1 | 2023 | 48 | 0.200 |
Why?
|
| Social Participation | 1 | 2022 | 11 | 0.200 |
Why?
|
| Age Factors | 7 | 2021 | 720 | 0.200 |
Why?
|
| Diet, Mediterranean | 1 | 2023 | 80 | 0.200 |
Why?
|
| Hemoglobins | 1 | 2022 | 76 | 0.190 |
Why?
|
| Cause of Death | 1 | 2021 | 56 | 0.190 |
Why?
|
| Ventriculostomy | 2 | 2012 | 4 | 0.190 |
Why?
|
| Lewy Bodies | 3 | 2019 | 191 | 0.190 |
Why?
|
| Cross-Sectional Studies | 8 | 2021 | 832 | 0.190 |
Why?
|
| Mathematics | 1 | 2021 | 31 | 0.190 |
Why?
|
| Social Discrimination | 1 | 2021 | 7 | 0.180 |
Why?
|
| Neuroticism | 1 | 2021 | 31 | 0.180 |
Why?
|
| Writing | 1 | 2021 | 18 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2021 | 44 | 0.180 |
Why?
|
| Reading | 1 | 2021 | 37 | 0.180 |
Why?
|
| Cerebral Infarction | 2 | 2023 | 149 | 0.180 |
Why?
|
| Medicare | 4 | 2024 | 107 | 0.180 |
Why?
|
| Agriculture | 3 | 2010 | 3 | 0.180 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 1622 | 0.170 |
Why?
|
| Influenza in Birds | 3 | 2011 | 3 | 0.170 |
Why?
|
| Physical Fitness | 1 | 2020 | 56 | 0.170 |
Why?
|
| Hypertension | 2 | 2020 | 234 | 0.170 |
Why?
|
| Adipokines | 1 | 2019 | 7 | 0.170 |
Why?
|
| Neurons | 1 | 2022 | 287 | 0.170 |
Why?
|
| Linear Models | 2 | 2020 | 231 | 0.170 |
Why?
|
| Exercise | 2 | 2021 | 447 | 0.170 |
Why?
|
| Adult | 18 | 2018 | 7087 | 0.170 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 16 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 328 | 0.160 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 18 | 0.160 |
Why?
|
| Cerebral Arteries | 2 | 2016 | 23 | 0.160 |
Why?
|
| Motor Disorders | 1 | 2019 | 24 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 33 | 0.160 |
Why?
|
| Aneurysm, Ruptured | 3 | 2018 | 12 | 0.160 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 60 | 0.160 |
Why?
|
| Neurofibrillary Tangles | 2 | 2017 | 188 | 0.160 |
Why?
|
| tau Proteins | 1 | 2020 | 216 | 0.160 |
Why?
|
| Memory Disorders | 1 | 2020 | 159 | 0.160 |
Why?
|
| Animal Husbandry | 2 | 2008 | 8 | 0.160 |
Why?
|
| Logistic Models | 2 | 2016 | 343 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 99 | 0.150 |
Why?
|
| Proteomics | 1 | 2019 | 87 | 0.150 |
Why?
|
| Neuroimaging | 1 | 2019 | 133 | 0.150 |
Why?
|
| Retrospective Studies | 5 | 2021 | 3105 | 0.150 |
Why?
|
| Rural Population | 3 | 2013 | 22 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 93 | 0.150 |
Why?
|
| Antibodies, Bacterial | 2 | 2008 | 18 | 0.150 |
Why?
|
| Learning | 1 | 2018 | 62 | 0.150 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 145 | 0.150 |
Why?
|
| Cerebral Hemorrhage | 2 | 2023 | 106 | 0.140 |
Why?
|
| Young Adult | 9 | 2015 | 1749 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2017 | 67 | 0.140 |
Why?
|
| Infant | 6 | 2023 | 483 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 186 | 0.140 |
Why?
|
| Agricultural Workers' Diseases | 2 | 2007 | 2 | 0.140 |
Why?
|
| Paramyxoviridae Infections | 2 | 2006 | 2 | 0.140 |
Why?
|
| Metapneumovirus | 2 | 2006 | 2 | 0.140 |
Why?
|
| Likelihood Functions | 1 | 2016 | 25 | 0.130 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 2 | 2013 | 2 | 0.130 |
Why?
|
| Brain Chemistry | 1 | 2016 | 40 | 0.130 |
Why?
|
| Hemagglutination Inhibition Tests | 3 | 2015 | 4 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2017 | 407 | 0.130 |
Why?
|
| Serologic Tests | 1 | 2015 | 9 | 0.120 |
Why?
|
| Horse Diseases | 1 | 2015 | 4 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 98 | 0.120 |
Why?
|
| Iowa | 6 | 2015 | 11 | 0.120 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 201 | 0.120 |
Why?
|
| Thiazolidinediones | 1 | 2014 | 7 | 0.110 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 7 | 0.110 |
Why?
|
| Pyridines | 1 | 2014 | 36 | 0.110 |
Why?
|
| Adolescent | 8 | 2015 | 1998 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 76 | 0.110 |
Why?
|
| Neutralization Tests | 2 | 2015 | 8 | 0.110 |
Why?
|
| Child | 7 | 2012 | 1232 | 0.100 |
Why?
|
| DNA, Viral | 2 | 2009 | 36 | 0.100 |
Why?
|
| Sclerosis | 3 | 2019 | 66 | 0.100 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2012 | 6 | 0.100 |
Why?
|
| Cerebellar Diseases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Third Ventricle | 1 | 2012 | 2 | 0.100 |
Why?
|
| Asymptomatic Infections | 1 | 2011 | 1 | 0.100 |
Why?
|
| Poultry Diseases | 1 | 2011 | 2 | 0.100 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 278 | 0.090 |
Why?
|
| Chicago | 3 | 2020 | 782 | 0.090 |
Why?
|
| Aspirin | 1 | 2011 | 73 | 0.090 |
Why?
|
| Decompression, Surgical | 1 | 2012 | 128 | 0.090 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 21 | 0.090 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 122 | 0.090 |
Why?
|
| Stents | 1 | 2010 | 64 | 0.090 |
Why?
|
| Self Report | 2 | 2021 | 199 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2015 | 309 | 0.080 |
Why?
|
| Adenoviridae Infections | 1 | 2009 | 1 | 0.080 |
Why?
|
| Mental Status and Dementia Tests | 2 | 2021 | 69 | 0.080 |
Why?
|
| Streptococcus suis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Streptococcal Infections | 1 | 2008 | 7 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2023 | 1113 | 0.080 |
Why?
|
| Cerebral Cortex | 2 | 2022 | 161 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2007 | 10 | 0.070 |
Why?
|
| Veterinarians | 1 | 2007 | 1 | 0.070 |
Why?
|
| Influenza A Virus, H5N2 Subtype | 1 | 2007 | 1 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 21 | 0.070 |
Why?
|
| Ehrlichiosis | 1 | 2006 | 1 | 0.070 |
Why?
|
| Anaplasma phagocytophilum | 1 | 2006 | 1 | 0.070 |
Why?
|
| Deer | 1 | 2006 | 2 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 2008 | 148 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 114 | 0.070 |
Why?
|
| Poultry | 3 | 2011 | 3 | 0.060 |
Why?
|
| Prevalence | 3 | 2014 | 422 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 539 | 0.060 |
Why?
|
| 5-Methylcytosine | 1 | 2023 | 4 | 0.050 |
Why?
|
| Comorbidity | 2 | 2014 | 451 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2015 | 116 | 0.050 |
Why?
|
| Horses | 2 | 2015 | 14 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 32 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2023 | 117 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2021 | 54 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 438 | 0.050 |
Why?
|
| Causality | 1 | 2020 | 47 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 467 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2014 | 3146 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 85 | 0.040 |
Why?
|
| Sex Factors | 2 | 2011 | 429 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2009 | 7 | 0.040 |
Why?
|
| Leptin | 1 | 2019 | 19 | 0.040 |
Why?
|
| Postmortem Changes | 1 | 2019 | 31 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 131 | 0.040 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 498 | 0.040 |
Why?
|
| Smoking | 1 | 2020 | 165 | 0.040 |
Why?
|
| Birds | 2 | 2008 | 5 | 0.040 |
Why?
|
| Social Isolation | 1 | 2018 | 22 | 0.040 |
Why?
|
| Mice | 1 | 2022 | 1197 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 2 | 2009 | 53 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2009 | 522 | 0.040 |
Why?
|
| Genotype | 2 | 2009 | 338 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2017 | 107 | 0.030 |
Why?
|
| Peru | 2 | 2007 | 3 | 0.030 |
Why?
|
| Religious Personnel | 1 | 2016 | 11 | 0.030 |
Why?
|
| PubMed | 1 | 2016 | 11 | 0.030 |
Why?
|
| Arterioles | 1 | 2016 | 9 | 0.030 |
Why?
|
| Phylogeny | 2 | 2006 | 44 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 50 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2016 | 39 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 537 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 20 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 69 | 0.030 |
Why?
|
| Models, Psychological | 1 | 2015 | 61 | 0.030 |
Why?
|
| Quality of Life | 1 | 2020 | 592 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 21 | 0.030 |
Why?
|
| Reaction Time | 1 | 2015 | 107 | 0.030 |
Why?
|
| beta 2-Glycoprotein I | 1 | 2014 | 7 | 0.030 |
Why?
|
| Phosphatidylserines | 1 | 2014 | 7 | 0.030 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2014 | 7 | 0.030 |
Why?
|
| Autoantigens | 1 | 2014 | 20 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2016 | 203 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 103 | 0.030 |
Why?
|
| Glucose | 1 | 2014 | 48 | 0.030 |
Why?
|
| Mental Status Schedule | 1 | 2014 | 93 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2014 | 35 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 46 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 77 | 0.030 |
Why?
|
| Memory | 1 | 2015 | 293 | 0.030 |
Why?
|
| Cambodia | 1 | 2013 | 19 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 413 | 0.030 |
Why?
|
| Brain Mapping | 1 | 2014 | 164 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 9 | 0.030 |
Why?
|
| Craniotomy | 1 | 2012 | 21 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 2012 | 2 | 0.030 |
Why?
|
| Central Nervous System Infections | 1 | 2012 | 3 | 0.030 |
Why?
|
| Radiography | 1 | 2014 | 572 | 0.020 |
Why?
|
| Hydrocephalus | 1 | 2012 | 19 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2012 | 111 | 0.020 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 1 | 0.020 |
Why?
|
| Thailand | 1 | 2011 | 10 | 0.020 |
Why?
|
| Preoperative Period | 1 | 2012 | 73 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 154 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 233 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2012 | 136 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 239 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2012 | 272 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2010 | 8 | 0.020 |
Why?
|
| Endovascular Procedures | 1 | 2010 | 26 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1327 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 42 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2010 | 38 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2012 | 276 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 195 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2009 | 6 | 0.020 |
Why?
|
| Connecticut | 1 | 2009 | 6 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2009 | 6 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2009 | 5 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2009 | 25 | 0.020 |
Why?
|
| Capsid Proteins | 1 | 2009 | 20 | 0.020 |
Why?
|
| Incidence | 1 | 2011 | 664 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 110 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2009 | 28 | 0.020 |
Why?
|
| Serotyping | 1 | 2008 | 10 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2008 | 29 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2008 | 18 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2008 | 10 | 0.020 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2008 | 31 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 39 | 0.020 |
Why?
|
| Methicillin Resistance | 1 | 2008 | 22 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 77 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2013 | 1036 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2008 | 60 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 5 | 0.020 |
Why?
|
| Carrier State | 1 | 2008 | 47 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 89 | 0.020 |
Why?
|
| Chickens | 1 | 2007 | 17 | 0.020 |
Why?
|
| Hemagglutination Tests | 1 | 2006 | 3 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 685 | 0.020 |
Why?
|
| Arachnid Vectors | 1 | 2006 | 1 | 0.020 |
Why?
|
| Ixodes | 1 | 2006 | 1 | 0.020 |
Why?
|
| Animals, Wild | 1 | 2006 | 2 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2006 | 6 | 0.020 |
Why?
|
| Disease Reservoirs | 1 | 2006 | 8 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2006 | 10 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 642 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2006 | 74 | 0.020 |
Why?
|
| Pharynx | 1 | 2006 | 13 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2006 | 38 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 173 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2006 | 46 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 128 | 0.020 |
Why?
|
| Hospitals | 1 | 2006 | 145 | 0.020 |
Why?
|
| Cell Line | 1 | 2006 | 240 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2006 | 93 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 299 | 0.010 |
Why?
|